Cargando...
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
SIMPLE SUMMARY: Cancer onset and progression are promoted by high deregulation of the immune system. Recently, major advances in molecular and clinical cancer immunology have been achieved, offering new agents for the treatment of common tumors, often with astonishing benefits in terms of prolonged...
Gardado en:
| Publicado en: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036682/ https://ncbi.nlm.nih.gov/pubmed/33808190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071587 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|